Jefferies analyst Maury Raycroft lowered the price target on Prime Medicine (NASDAQ: PRME) to $9.00 (from $13.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE